Age at diagnosis and prognosis in children with neuroblastoma

Journal of Clinical Oncology

Volumn 23, Issue 27, 2005, Pages 6443-6444

  Evans, Audrey E ^a   D'Angio, Giulio J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; EDITORIAL; GENE AMPLIFICATION; HUMAN; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION; AGE; CANCER STAGING; CHILD; COMPARATIVE STUDY; FEMALE; INFANT; MALE; MORTALITY; NOTE; PRESCHOOL CHILD; RISK ASSESSMENT; SURVIVAL;

ANTINEOPLASTIC AGENT;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 27244440756     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.005     Document Type: Editorial

References (12)

1. London WB, Castleberry RP, Matthay KK, et al: Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol 23:6459-6465, 2005
2. George RE, London WB, Cohn S, et al: Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: A Pediatric Oncology Group Study. J Clin Oncol 23:6466-6473, 2005
3. Schmidt M L, Lal A, Seeger R, et al: Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: A Children's Cancer Group Study. J Clin Oncol 23:6474-6480, 2005
4. Wittenborg MH: Roentgen therapy in neuroblastoma: Review of 73 cases. Radiology 54:670-688, 1950
5. Everson TC, Cole WH. Spontaneous Regression of Cancer. Philadelphia, PA, WB Saunders, 1966
6. Bill HA, Koop CE: The biology of neuroblastoma. J Pediatr Surgery 3:103-193, 1968
7. Beckwith JB, Perrin EV: In situ neuroblastoma: A contribution to the natural history of neural crest tumors. Am J Pathol 43:1089-1104, 1963
8. Breslow N, McCann B: Statistical estimation of the prognosis for children with neuroblastoma. Cancer Res 31:2098-2103, 1971
9. Brodeur GM, Seeger RC, Schwab M, et al: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124, 1984
10. Look AT, Hayes FA, Nitschke R, et al: Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 311:231-235, 1984
11. Shimada H, Chaten J, Newton WAJ, et al: Histologic prognostic factors in neuroblastoma tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastoma. J Natl Cancer Inst 73:405-406, 1984
12. Wolff JA, D'Angio GJ, Hartman WA, et al: Long term evaluation of single vs. multiple courses of actinomycin-D therapy of Wilms' tumor. N Engl J Med 209:84-86, 1974